Drugs / Enriched Hematopoetic Stem Cell Infusion
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT02021266 | — | metachromatic leukodystrophy | Talaris Therapeutics Inc. | No longer available | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Enriched Hematopoetic Stem Cell Infusion | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02021266 ↗ |
| Modality | Cell therapy | “facilitating cell-enhanced hematopoietic stem cell product” NCT02021266 ↗ |